About
Served as the first President & CEO of OVI at its inception in May 2020 and now acts as Investment/Operation Senior Advisor. Has extensive experience in pharmacological research, business development, and management. Holds an MSc in Pharmacy from Kyoto Pharmaceutical University.
Colleagues at Ono Venture Investment, Inc.
Daisuke Nakayama
Vice President at Ono Venture Investment, Inc.
Haruhito Tsutsui
Investment Director at Ono Venture Investment, Inc.
Kousuke Tani
Senior Investment Director at Ono Venture Investment, Inc.
Ryohei Miyata
Director, Scientific Relations at Ono Venture Investment, Inc.
Shunichiro Matsumoto
President and CEO at Ono Venture Investment, Inc.